What Provectus Algae does
Provectus Algae Pty Ltd is a biosolutions company that searches a library of photosynthetic microbes for species able to solve a defined industrial problem. The company says the library has never been mined before and holds more than 200 species. Its model is to pick a problem, screen the library and build a product around the result.
The home page lists four markets: agricultural feed, food and beverage and nutraceuticals, crop protection and biostimulants, and antimicrobials. Food is therefore one possible destination rather than the present focus. Readers who want to know how finished microalgae foods behave can look at spirulina and chlorella, which are established food algae with documented compositions.
The only product the site describes in detail is Surf’N’Turf, a dry feed supplement for ruminant livestock. The company says it reduces methane and improves feed digestion, and reports five completed pilots covering 3,000 animals. The subsidiary Proteus Ag is commercialising it. Five further products are in development, alongside a second company working on astaxanthin.
Precision Photosynthesis and the platform
The platform page describes a system that joins biology, hardware and software. Its central idea, which the company calls Precision Photosynthesis, is that precisely tuned light spectra control gene expression, growth and the molecules a cell synthesises. The company reports validation across volatile compounds, proteins, carotenoids, fatty acids and saccharides, so the same species can be pushed towards different outputs.
Discovery relies on Magellan, which the company calls the largest natural-products database for algae, built with an omics-driven web crawler and language processing. Candidate biology is then improved through light-based optimisation and recombinant genetic engineering. The page says 22 species have been optimised so far. A buyer should ask which relate to an ingredient on offer.
An automated foundry runs parallel experiments and records light, chemistry and cell response continuously. A computational microscope called Cell Analytics extracts 116 culture metrics and predicts productivity above 88 percent at 24 hours. Bioreactors range from 50 millilitres to 5,000 litres, and recipes are said to reproduce through scale-up to 260 kiloliters in modular, continuous facilities.
Why microalgae matter to food developers
Microalgae can make protein, lipids, pigments and other bioactives from light and simple nutrients, often away from cropland. The trade-off is cost. Light delivery, harvesting dilute cultures and drying are expensive steps, which is why algae usually enter high-value uses first. Feed and nutraceuticals sit nearer that threshold than bulk protein.
Algal biomass in a food raises questions of colour, taste and regulatory status. Green or blue pigments can tint a formulation strongly, and a marine or earthy flavour often needs masking. Novel species need a novel food assessment in the European Union and comparable procedures elsewhere. The company’s pages state no food approvals, so confirm the position directly.
Because the platform can steer composition with light, a single species might supply different fractions for different customers. That flexibility also raises specification questions. A food technologist should insist on a fixed specification for each lot covering protein, lipid, pigment, ash, moisture, heavy metals and microbial counts, and on documented control of the light regime.
How a buyer would evaluate the company
Start by identifying which product or species is actually on offer. The website presents a platform and a first feed product, not a catalogue of food ingredients, so a food buyer should arrive with a defined target, such as a pigment, a lipid fraction or a protein concentrate, and ask whether it has been shown at pilot scale.
Ask for the regulatory route and timeline. Request the taxonomy of the species, the genetic status of the strain, the safety data available and the jurisdictions where the material has been assessed. Recombinant genetic engineering is mentioned on the platform page, so the genetic modification status of any strain proposed for food must be stated plainly before development starts.
Finally, examine the economics and the partnership model. The company invites partners through its contact page and operates through subsidiaries for specific products. Ask about minimum volumes, who owns formulations created jointly, how production at the quoted scale is secured, and what happens if target performance is missed. Staged agreements with milestones limit risk.